Versatile Polymer-Initiating Biomineralization for Tumor Blockade Therapy

Area of Science:

• Biomaterials Science
• Nanotechnology
• Oncology

Background:

• Tumor blockade therapy shows promise for inhibiting tumor growth by restricting nutrient and oxygen exchange.
• Current blockade strategies face limitations including inadequate obstruction, potential side effects, and short-lived effects.
• Osteosarcoma presents a significant challenge due to its invasive nature and propensity for metastasis.

Purpose of the Study:

• To develop a novel polymer-based blockade therapy for osteosarcoma.
• To create a physical barrier around tumors using biomineralization.
• To investigate the efficacy of this approach in inhibiting primary tumor growth and pulmonary metastasis.

Main Methods:

• Synthesis of a versatile polymer, 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-poly(ethylene glycol)-alendronate (DSPE-PEG-ALN, DPA).
• Utilizing the DSPE moiety for cell membrane insertion and the alendronate (ALN) component for ion attraction and biomineralization.
• In situ formation of a biomineral shell around osteosarcoma cells following injection into tumor tissue.

Main Results:

• DSPE-PEG-ALN successfully inserted into cell membranes and initiated continuous mineral deposition, forming a physical tumor barrier.
• The biomineralization effectively inhibited the growth of primary osteosarcoma and reduced pulmonary metastasis.
• Alendronate component demonstrated a secondary benefit by suppressing osteoclast activity, mitigating bone destruction.

Conclusions:

• The developed multifunctional polymer-initiating blockade therapy offers a potent strategy for osteosarcoma treatment.
• Biomineralization-induced physical barriers provide effective tumor obstruction with minimal side effects.
• This approach holds significant potential for clinical translation in cancer therapy.